Jump Financial, LLC Pyxis Oncology, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.83 - $3.94 $39,288 - $54,699	-13,883 Closed	0 $0
Q2 2024 Aug 14, 2024	SELL	$3.06 - $5.58 $81,301 - $148,255	-26,569 Reduced 65.68%	13,883 $45,000
Q1 2024 May 13, 2024	BUY	$2.03 - $6.59 $82,117 - $266,578	40,452 New	40,452 $172,000
Q2 2023 Oct 21, 2024	BUY	$2.46 - $4.07 $42,171 - $69,772	17,143 Added 123.48%	31,026 $79,000
Q2 2023 Aug 07, 2023	BUY	$2.46 - $4.07 $76,323 - $126,275	31,026 New	31,026 $79,000

101

28.2M

539K

54.1K

Ticker PYXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,096,400
Market Cap $59.3M
Description
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.